rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2001-10-29
|
pubmed:abstractText |
Glucagon-like peptide-1 (GLP-1) is an intestinal insulinotropic hormone that augments glucose-induced insulin secretion in patients with type 2 diabetes. It has also been proposed that a substantial component of the glucose-lowering effects of GLP-1 occurs because this hormone enhances insulin-mediated glucose disposal. However, interpretations of the studies have been controversial. This study determines the effect of GLP-1 on insulin-mediated glucose disposal in elderly patients with type 2 diabetes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1079-5006
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
M681-5
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11682575-Aged,
pubmed-meshheading:11682575-Biological Transport, Active,
pubmed-meshheading:11682575-Blood Glucose,
pubmed-meshheading:11682575-C-Peptide,
pubmed-meshheading:11682575-Diabetes Mellitus, Type 2,
pubmed-meshheading:11682575-Glucagon,
pubmed-meshheading:11682575-Glucagon-Like Peptide 1,
pubmed-meshheading:11682575-Glucagon-Like Peptides,
pubmed-meshheading:11682575-Glucose,
pubmed-meshheading:11682575-Glucose Clamp Technique,
pubmed-meshheading:11682575-Humans,
pubmed-meshheading:11682575-Insulin,
pubmed-meshheading:11682575-Peptide Fragments,
pubmed-meshheading:11682575-Peptides
|
pubmed:year |
2001
|
pubmed:articleTitle |
Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.
|
pubmed:affiliation |
Department of Medicine, University of British Columbia, Vancouver, Canada. meneilly@interchange.ubc.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|